RPG Investment Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-83,633
| Closed | -$7.73M | – | 100 |
|
|
2024
Q4 | $7.73M | Sell |
83,633
-245
| -0.3% | -$22.1K | 1.04% | 42 |
|
|
2024
Q3 | $7.03M | Sell |
83,878
-16,087
| -16% | -$1.23M | 1% | 46 |
|
|
2024
Q2 | $6.86M | Buy |
99,965
+23,665
| +31% | +$1.58M | 1.01% | 41 |
|
|
2024
Q1 | $5.59M | Buy |
76,300
+4,890
| +7% | +$376K | 0.84% | 48 |
|
|
2023
Q4 | $5.78M | Buy |
71,410
+1,659
| +2% | +$129K | 0.94% | 46 |
|
|
2023
Q3 | $5.23M | Buy |
69,751
+1,409
| +2% | +$108K | 0.96% | 44 |
|
|
2023
Q2 | $5.27M | Sell |
68,342
-1,242
| -2% | -$99.1K | 0.91% | 48 |
|
|
2023
Q1 | $5.77M | Sell |
69,584
-30,812
| -31% | -$2.55M | 1.02% | 45 |
|
|
2022
Q4 | $8.62M | Sell |
100,396
-42,268
| -30% | -$3.35M | 1.66% | 23 |
|
|
2022
Q3 | $8.8M | Sell |
142,664
-1,064
| -0.7% | -$67.1K | 1.9% | 18 |
|
|
2022
Q2 | $8.88M | Buy |
143,728
+2,014
| +1% | +$125K | 1.8% | 17 |
|
|
2022
Q1 | $8.43M | Buy |
141,714
+931
| +0.7% | +$59.5K | 1.38% | 32 |
|
|
2021
Q4 | $10.2M | Buy |
140,783
+2,999
| +2% | +$207K | 1.59% | 18 |
|
|
2021
Q3 | $9.62M | Sell |
137,784
-778
| -0.6% | -$54.7K | 1.59% | 21 |
|
|
2021
Q2 | $9.54M | Buy |
138,562
+11,642
| +9% | +$777K | 1.56% | 19 |
|
|
2021
Q1 | $8.2M | Buy |
126,920
+1,544
| +1% | +$99.6K | 1.47% | 19 |
|
|
2020
Q4 | $7.3M | Buy |
125,376
+11,756
| +10% | +$709K | 1.47% | 26 |
|
|
2020
Q3 | $7.18M | Buy |
113,620
+1,629
| +1% | +$113K | 1.76% | 14 |
|
|
2020
Q2 | $8.62M | Sell |
111,991
-260
| -0.2% | -$19.9K | 2.28% | 9 |
|
|
2020
Q1 | $8.39M | Sell |
112,251
-1,350
| -1% | -$93.3K | 2.38% | 7 |
|
|
2019
Q4 | $7.38M | Buy |
113,601
+1,888
| +2% | +$123K | 1.69% | 14 |
|
|
2019
Q3 | $7.08M | Buy |
111,713
+4,593
| +4% | +$300K | 1.68% | 15 |
|
|
2019
Q2 | $7.24M | Buy |
107,120
+4,706
| +5% | +$310K | 1.71% | 16 |
|
|
2019
Q1 | $6.66M | Buy |
102,414
+289
| +0.3% | +$19.2K | 1.56% | 18 |
|
|
2018
Q4 | $6.39M | Buy |
102,125
+111
| +0.1% | +$7.76K | 1.59% | 14 |
|
|
2018
Q3 | $7.88M | Sell |
102,014
-419
| -0.4% | -$31.6K | 1.65% | 13 |
|
|
2018
Q2 | $7.26M | Buy |
102,433
+1,604
| +2% | +$113K | 1.63% | 20 |
|
|
2018
Q1 | $7.6M | Sell |
100,829
-466
| -0.5% | -$37K | 1.74% | 15 |
|
|
2017
Q4 | $7.26M | Buy |
101,295
+1,554
| +2% | +$118K | 1.76% | 16 |
|
|
2017
Q3 | $8.08M | Sell |
99,741
-66
| -0.1% | -$5.05K | 2.06% | 9 |
|
|
2017
Q2 | $7.06M | Buy |
99,807
+12,222
| +14% | +$813K | 1.93% | 11 |
|
|
2017
Q1 | $5.95M | Buy |
87,585
+12,116
| +16% | +$852K | 1.74% | 14 |
|
|
2016
Q4 | $5.4M | Buy |
75,469
+7,733
| +11% | +$575K | 1.83% | 12 |
|
|
2016
Q3 | $5.36M | Sell |
67,736
-2,599
| -4% | -$211K | 1.67% | 15 |
|
|
2016
Q2 | $5.86M | Buy |
70,335
+40,002
| +132% | +$3.55M | 1.57% | 16 |
|
|
2016
Q1 | $2.79M | Sell |
30,333
-389
| -1% | -$35.1K | 1.08% | 38 |
|
|
2015
Q4 | $3.11M | Buy |
+30,722
| New | +$3.2M | 1.16% | 37 |
|
Other funds holding GILD
RPG Investment Advisory's GILD Position: Q1 2025 in Review
RPG Investment Advisory sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 83,633 shares — an estimated $7.73M sold.
RPG Investment Advisory first reported a position in GILD in Q4 2015 and held it in 37 quarters. The position peaked at $10.2M in Q4 2021. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- RPG Investment Advisory reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- RPG Investment Advisory sold 83,633 Gilead Sciences shares in Q1 2025, an estimated $7.73M.
- RPG Investment Advisory first reported a position in Gilead Sciences in Q4 2015 and held it in 37 quarters.
- RPG Investment Advisory's Gilead Sciences position peaked at $10.2M in Q4 2021.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on RPG Investment Advisory's 13F filing for Q1 2025, filed 14 May 2025.